Document is current
Any future updates will be listed below
-
Authors
Sun, Yaoting https://orcid.org/0000-0001-7613-648X
Wang, He https://orcid.org/0000-0001-6169-4278
Li, Lu
Wang, Jianbiao
Chen, Wanyuan
Peng, Li https://orcid.org/0000-0001-9331-6431
Hu, Pingping
Yu, Jing
Cai, Xue
Yao, Nan
Zhou, Yan
Wang, Jiatong
Wang, Yingrui https://orcid.org/0000-0001-5532-3454
Qian, Liqin
Ge, Weigang https://orcid.org/0000-0002-1803-4327
Chen, Mengni https://orcid.org/0009-0008-0327-4935
Yang, Feng
Gui, Zhiqiang
Sun, Wei
Wang, Zhihong
Ge, Minghua
He, Yi
Wang, Guangzhi
Zhao, Yongfu
Chen, Huanjie
Wu, Xiaohong
Du, Yuxin
Wei, Wenjun
Wu, Fan
Luo, Dingcun
Lin, Xiangfeng
Zheng, Haitao
Zhu, Xin
Wei, Bei
Shen, Jiafei
Yao, Jincao
Yuan, Zhennan
Liu, Tong
Pan, Jun
Zhang, Yifeng
Lv, Yangfan
Guo, Qiaonan
Wu, Qijun
Gong, Tingting
Chen, Ting
Zheng, Shu
Zhu, Jingqiang
Liu, Hanqing
Chen, Chuang https://orcid.org/0000-0003-4285-4496
Han, Hong
Selvarajan, Sathiyamoorthy
Xing, Michael Mingzhao
Kakudo, Kennichi https://orcid.org/0000-0002-0347-7264
Alexander, Erik K
Wu, Yijun
Wang, Yu
Xu, Dong
Zhang, Hao
Nie, Xiu
Kon, Oi Lian
Iyer, N Gopalakrishna
Liu, Zhiyan https://orcid.org/0000-0001-9668-7756
Zhu, Yi https://orcid.org/0000-0003-0429-0802
Guan, Haixia https://orcid.org/0000-0003-3155-2847
Guo, Tiannan https://orcid.org/0000-0003-3869-7651
,
-
Funding
Funding for this research was provided by:
MOST | National Key Research and Development Program of China (2022YFF0608403)
MOST | National Key Research and Development Program of China (2021YFA1301600)
China Postdoctoral Science Foundation (2022M722841)
Pioneer and Leading Goose R&D Program of Zhejiang (2024SSYS0035)
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0525603)
- License Information
-
More Information
Article History
Received: 13 January 2025
Revised: 22 April 2025
Accepted: 25 April 2025
First Online: 29 May 2025
Disclosure and competing interests statement
: T Guo and Y Zhu are shareholders of Westlake Omics Inc. MC and WG are employees of Westlake Omics Inc. FY is a shareholder of the RIGEN Biotechnology Co., Ltd. T Guo, YS, and HW have applied for a patent [ID: ZL 2022 1 1046085.8] on this project. The other authors declare no competing interests in this paper.
